China: A recent study revealed that combining semaglutide and metformin significantly improved liver inflammation, fibrosis, ...

Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in ...

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

The top content from the Institute for Value-Based Medicine® (IVBM®) highlighted innovative approaches to improving care ...

Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...

Body mass index (BMI) and obesity prevalence declined in the United States in 2023, according to a research letter published ...

Zepbound is the first medication approved to treat people with obstructive sleep apnea, said Sailly Seymor, director of FDA's ...

Today, the U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 ...

Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down the risks of the trend.

The U.S. Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the ...

The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...